Dr. Valerie Wells
Valerie Wells is research scientist in the Pharmaceutical Science Research Division at King’s College London. Her research is focused on defining differences in the signalling pathways which operate in normal and cancer cells, in order to exploit differences in their genetic makeup which can be targeted to selectively activate programmed cell death in cancer cells while leaving normal cells unharmed. A novel cytokine, βGBP, has been identified and cloned and has been found to selectively induce apoptosis in cancer cells. Valeries Wells is currently investigating the molecular signalling pathways activated by βGBP leading to programmed cell death.
